Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab

Elisabetta Munzone, F. Nolè, G. Sanna, A. Goldhirsch

Research output: Contribution to journalArticlepeer-review


Intraocular metastases, especially those of the choroidal plexus, are not common in metastatic breast cancer patients and are typically associated with a poor prognosis and impaired quality of life. A 45-year-old woman with breast cancer overexpressing HER2 and metastasizing to choroidal plexus, lymph nodes and skin received a combination of trastuzumab and paclitaxel as first-line treatment. Subsequently, at progression, trastuzumab was reintroduced together with vinorelbine. Administration of trastuzumab with either paclitaxel or vinorelbine led to a rapid improvement of the ocular symptoms, associated with a rapid objective response of all metastatic lesions and a prompt improvement in the quality of life. Choroidal metastases from breast cancer overexpressing HER2 are responsive to trastuzumab and chemotherapy (paclitaxel or vinorelbine). The susceptibility of ocular metastases to this approach seems different to that of other sanctuary disease sites.

Original languageEnglish
Pages (from-to)380-383
Number of pages4
Issue number5
Publication statusPublished - Oct 2005


  • Breast cancer
  • Choroidal metastasis
  • HER2 overexpression
  • Trastuzumab

ASJC Scopus subject areas

  • Obstetrics and Gynaecology


Dive into the research topics of 'Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab'. Together they form a unique fingerprint.

Cite this